000			01487 a2200433 4500
005			20250513002750.0
264		0	_c19821216
008			198212s 0 0 eng d
022			_a0028-8446
040			_aNLM _beng _cNLM
100	1		_aBunton, R W
245	0	0	_aReintroduction of anti-inflammatory drug therapy after drug-associated gastro-intestinal disturbances. _h[electronic resource]
260			_bThe New Zealand medical journal _cAug 1982
300			_a582-4 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAged
650	0	4	_aAnti-Inflammatory Agents _xadverse effects
650	0	4	_aArthritis _xdrug therapy
650	0	4	_aDuodenal Ulcer _xchemically induced
650	0	4	_aFemale
650	0	4	_aGastrointestinal Hemorrhage _xchemically induced
650	0	4	_aHumans
650	0	4	_aIbuprofen _xtherapeutic use
650	0	4	_aIndomethacin _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOsteoarthritis _xdrug therapy
650	0	4	_aPeptic Ulcer _xchemically induced
650	0	4	_aPeptic Ulcer Hemorrhage _xchemically induced
650	0	4	_aRecurrence
650	0	4	_aRetrospective Studies
650	0	4	_aSalicylates _xtherapeutic use
650	0	4	_aSuppositories
650	0	4	_aTime Factors
700	1		_aBarrett, D C
700	1		_aPalmer, D G
773	0		_tThe New Zealand medical journal _gvol. 95 _gno. 714 _gp. 582-4
999			_c6982114 _d6982114